Polo Ralph Lauren has come up short in its opposition to a deregistered company’s bid to register a polo player trade mark.
A US sports news website founded by former Yankees shortstop Derek Jeter featuring content by athletes has filed a lawsuit alleging an Australian sports site has violated its IP.
Australian food manufacturer Trident Foods has won a partial victory after facing two appeals from US seafood giant Trident Seafoods seeking to remove its trade marks.
The Australian Patent Office has thrown out Fisher & Paykel Healthcare’s opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.
Canada’s Vector Corrosion is suing Australia’s Duoguard and its UK supplier alleging the companies are infringing one of its patents for technology used to prevent corrosion of steel-reinforced concrete.
Hytera Communications wants the Federal Court to block Motorola from accessing evidence in their patent war covered by Chinese laws prohibiting disclosure of state secrets or compromising the country’s cybersecurity.
A Melbourne cafe embroiled in a Fair Work battle over alleged staff underpayments has now been hit with a $185,000 fine for copyright infringement in a separate case brought against it by the Phonographic Performance Company of Australia.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
Take-Two interactive has won an injunction blocking a Grand Theft Auto gamer from distributing software that allows users to access restricted features of the popular game, a month after reaching a settlement with a gamer in a separate copyright case.
Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world’s best-selling vaccine.